News from implant sciences corporation A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Nov 14, 2001, 00:00 ET

Implant Sciences Corporation Reports 58% Increase in First Quarter Revenue; Net Loss is Reduced By 42% Versus Prior-Year Period

WAKEFIELD, Mass., Nov. 14 /PRNewswire/ -- Implant Sciences Corporation (Amex: IMX; IMX.WS), which develops medical products for radiation...

Nov 05, 2001, 00:00 ET

Implant Sciences Exhibits Prostate Cancer Seeds and Vascular Brachytherapy Devices at American Society for Therapeutic Radiology and Oncology Conference

WAKEFIELD, Mass., Nov. 5 /PRNewswire/ -- Implant Sciences Corporation (Amex: IMX, IMX.WS), which develops products for the radiation oncology,...

Oct 17, 2001, 01:00 ET

Implant Sciences Corporation Reports FY2001 Operating Results And Continued Strong Growth in Sales of Radioactive Prostate Seeds

WAKEFIELD, Mass., Oct. 17 /PRNewswire/ -- Implant Sciences Corporation (Amex: IMX, IMX.WS), which develops products for the radiation oncology,...

Sep 25, 2001, 01:00 ET

Implant Sciences Awarded Over $1,000,000 in Government Grants and Contracts

WAKEFIELD, Mass., Sept. 25 /PRNewswire/ -- Implant Sciences Corporation (Amex: IMX), which manufactures I-Plant(TM) Iodine-125 brachytherapy...

Sep 11, 2001, 01:00 ET

Implant Sciences to Expand Production Workforce By 50% to Meet Growing Demand for Company's I-Plant(TM) Radioactive Prostate Seeds

WAKEFIELD, Mass., Sept. 11 /PRNewswire/ -- Implant Sciences Corporation (Amex: IMX), which manufactures I-Plant(TM) Iodine-125 brachytherapy...

Aug 29, 2001, 01:00 ET

Implant Sciences Corporation and CardioTech International Announce Development of Drug-Eluting Stent

WAKEFIELD, Mass. and WOBURN, Mass., Aug. 29 /PRNewswire/ -- Implant Sciences Corporation (Amex: IMX) and CardioTech International, Inc. (Amex:...

Jul 31, 2001, 01:00 ET

Implant Sciences Announces 'CE Mark' for Its I-Plant(TM) Brachytherapy Seeds Used for the Treatment of Prostate Cancer

WAKEFIELD, Mass., July 31 /PRNewswire/ -- Implant Sciences Corporation (Amex: IMX, IMX.WS), which develops products for the radiation oncology,...

Jul 23, 2001, 01:00 ET

Implant Sciences Exhibits its I-Plant(TM) Seed Used in the Treatment Of Prostate Cancer and Vascular Brachytherapy Devices at the AAPM Annual Meeting and Technical Exhibitions

WAKEFIELD, Mass., July 23 /PRNewswire/ -- Implant Sciences Corporation (Amex: IMX, IMX.WS), which develops products for the radiation oncology,...

Jul 17, 2001, 01:00 ET

Implant Sciences Retains RJ Falkner & Company As Investor Relations Counsel

WAKEFIELD, Mass., July 17 /PRNewswire/ -- Implant Sciences Corporation (Amex: IMX, IMX.WS), which develops products for the radiation oncology,...

Jun 03, 1999, 01:00 ET

Implant Sciences Corporation Receives FDA 510(k) Clearance to Market Iodine -- 125 Brachytherapy Seeds

WAKEFIELD, Mass., June 3 /PRNewswire/ -- Implant Sciences Corporation announced today that the U.S. Food and Drug Administration (FDA) has...

Feb 17, 1999, 00:00 ET

Implant Sciences Corporation Files For Initial Public Offering

WAKEFIELD, Mass., Feb. 17 /PRNewswire/ -- Implant Sciences Corporation announced today that it has filed a registration statement with the...